Changes in Nociceptive Thresholds and Adenylyl Cyclase System Activity in Skeletal Muscles in Rats with Acute and Mild Type 1 Diabetes
- 22 Downloads
Diabetic peripheral neuropathy (DPN) is one of the commonest complications of type 1 diabetes mellitus (DM1). The aims of the present work were to study the dynamics of the development of pain-type DPN and the functional status of the hormone-sensitive adenylyl cyclase signal system (ACSS) in the skeletal muscle of rats with models of acute and mild DM1 and to investigate the influences on these of insulin therapy using different routes of hormone administration – intranasal and peripheral. The nociceptive threshold in rats decreased in both models of DM1; the stimulatory effects of guanine nucleotides (GIDP) and adrenergic agonists (isoproterenol, BRL-37344) on adenylyl cyclase (AC) also decreased. The AC-stimulating effect of relaxin decreased in animals with acute DM1, while the change in mild DM1 was minor. Peripheral administration of insulin to rats with acute DM1 increased the nociceptive threshold and partially restored the AC effect of the β3 agonist BRL-37344. Intranasal administration of insulin to rats with mild DM1 also led to an increase in the nociceptive threshold and partially restored basal and BRL-37344-stimulated AC activity in the skeletal muscle of diabetic animals. Thus, skeletal muscle in rats with acute and mild DM1 showed impaired nociceptive sensitivity and ACSS function, which was partially restored by treatment of animals with insulin given peripherally (acute DM1) or intranasally (mild DM1).
Keywordsdiabetes mellitus diabetic peripheral neuropathy insulin intranasal administration mechanical nociceptive threshold adenylyl cyclase
Unable to display preview. Download preview PDF.
- 3.American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care,, 37, Suppl. 1, S81–S90 (2014).Google Scholar
- 5.G. J. Biessels, N. A. Cristino, G. J. Rutten, et al., “Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Course of development and effects of insulin treatment,” Brain, 122, No. Part 4, 757–768 (1999).Google Scholar
- 14.J. R. Hadcock, J. D. Port, M. S. Gelman, and C. C. Malbon, “Crosstalk between tyrosine kinase and G-protein-linked receptors. Phosphorylation of beta 2-adrenergic receptors in response to insulin,” J. Biol. Chem., 267, No. 36, 26 017–26 022 (1992).Google Scholar
- 22.J. Piriz, I. Torres-Aleman, and Nunez, “Independent alterations in the central and peripheral somatosensory pathways in rat diabetic neuropathy,” Neuroscience, 160, No. 2, 402–411 (2009).Google Scholar
- 26.J. G. Ryall, D. R. Plant, P. Gregorevic, et al., “Beta 2-agonist administration reverses muscle wasting and improves muscle function in aged rats,” J. Physiol., 555, Pt. 1, 175–188 (2004).Google Scholar
- 28.A. O. Shpakov, O. V. Chistyakova, K. V. Derkach, et al., “Intranasal insulin affects adenyl cyclase system in rat tissues in neonatal diabetes,” Cent. Eur. J. Biol., 7, No. 1, 33–47 (2012).Google Scholar
- 29.A. O. Shpakov and K. V. Derkach, “The functional state of hormone-sensitive adenylyl cyclase signaling system in diabetes mellitus,” J. Signal Transduct., 2013, 594213 (2013).Google Scholar
- 30.A. O. Shpakov, L. A. Kuznetsova, S. A. Plesneva, et al., “Functional defects in adenylyl cyclase signaling mechanisms of insulin and relaxin in skeletal muscles of rat with streptozotocin type 1 diabetes,” Cent. Eur. J. Biol., 1, No. 4, 530–544 (2006).Google Scholar